The State Pharmacopoeia of the Russian Federation

Similar documents
State Pharmacopoeia of Ukraine

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

Indian Pharmacopoeia Commission

Requirements to the Registration of Medicinal products in the Republic of Armenia

Kazuhiko Mori Ministry of Health, Labour and Welfare

EDQM and European Pharmacopoeia: State-of-the-art Science for Tomorrow s Medicines

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON DISINTEGRATION TEST GENERAL CHAPTER Q4B ANNEX 5(R1)

Residual Solvents: FDA/ Regulatory Perspective

General concepts in the Ph. Eur.: theory and rationale

General Concepts in the European Pharmacopoeia. Anne-Sophie Bouin European Pharmacopoeia Department, EDQM, Council of Europe

WHITE PAPER ACCESS TO GOOD QUALITY DIETARY SUPPLEMENTS

Pharmakon drug Poiea to make Government of each country List of Pharmacopeias: British European Indian International United state.

The International Pharmacopoeia - Overview

Overview of USP General Chapters <476> and <1086> Prescription/Non-Prescription Stakeholder Forum October 19, 2017

GUIDE TO REGISTER HOMEOPATHIC PRODUCTS FOR VETERINARY USE

DIRECTIVE 2004/24/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 31 March 2004

Recognized Pharmacopoeia in Registration system

Topics covered by the talk

Future of Homeopathy. Robert Melo M.D.

Russian Society of Cardiology: an example of a successful National Cardiac Society membership scheme

USP Perspective on Atypical Actives November 29, 2017

HOMEOPATHIC MEDICINAL PRODUCT WORKING GROUP (HMPWG) DRAFT (12/08) POINTS TO CONSIDER ON STABILITY TESTING OF HOMEOPATHIC MEDICINAL PRODUCTS

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

R&D Status in Romania

Test Bank for Basic Pharmacology for Nurses 14th edition by Clayton, Stock and Harroun

Research on the Administrative Rules of APIs, Pharmaceutical Excipients and Auxiliary Materials Master File. Translation version

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Dagmar Roth-Behrendt Vice-President of the European Parliament

Much Ado About Nothing: Cannabis and the Current Administration

Self sufficiency program

Regulation of Herbal and Traditional Medicines in Germany BfArM in Dialogue - TradReg 2017

REGULATION concerning Marketing Authorisations for Natural Medicinal Products and Registration of Traditional Herbal Medicinal Products, No. 142/2011.

China Insulin Industry Report, Jan. 2011

Review Article ISSN: Open Access. Regulatory Aspects of Pharmaceutical Excipients in India and their Qualification to Use in Pharmaceuticals

Health Products Regulatory Authority IPAR. Public Assessment Report for a. Traditional Herbal Medicinal Product

Questions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to

WCO ACTION PLAN FOR THE ECONOMIC COMPETITIVENESS PACKAGE

Russia. Anna McDonald and Dmitry Dementyev. Salans

MEDICINES ACT 395/1987. Unofficial translation; Amendments up to 1340/2010 included

Ms. Fortunate Fakudze Senior Pharmacist Ministry of Health KINGDOM OF SWAZILAND

Tamsulosin Hydrochloride 0.4 mg Capsule

Agenda. The current state of Pharmaceutical Excipients in Japan -JPE, JP, DMF, GAB (GMP Auditing Board)- Pharmaceutical Excipients

Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation

Federation of Saint Kitts and Nevis

quality and safety of pharmacy preparations in Europe

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Update from FDA Office of Regulatory Affairs

Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products 1

Traditional Medicine: Overview on national policies and regulations of traditional medicine

National Transition Strategy to Replace CFC-based. MDIs with in the Commonwealth of Independent States. Paul Krajnik UNIDO, Montreal Protocol Branch

The European Union CD 1999/83/EEC on well-established use

Good pharmacopoeial practices: Chapter on monographs on herbal medicines

EMEA WORKING PARTY ON HERBAL MEDICINAL PRODUCTS

INDONESIA HEALTH CARE SECTOR CHANGE OF PARADIGM

BMSTU in PEN- International

Dr. Christian Zeine LGC Standards GmbH. Webinar Series 2013 July 2013

Public Assessment Report Scientific discussion. Ginsana, oral solution. Asp.no.:

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

H 7816 S T A T E O F R H O D E I S L A N D

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL COMMUNITY HERBAL MONOGRAPH ON PASSIFLORA INCARNATA L., HERBA

Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far

Discussion by HMPC Drafting Group on Quality February Start of public consultation 27 June 2012

Compounding Pharmacy Pharmacy s Past, Present & Future

RESULTS AND DISCUSSION

Discussion by HMPC Drafting Group on Quality September Start of public consultation 15 February 2013

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia

Patented Medicine Prices Review Board (PMPRB) Fasken Martineau Pharmaceutical Law Seminar April 29, 2010, Montréal

Public Assessment Report for a Homeopathic Medicinal Product for Human Use

Announcement regarding the publication of the results of clinical trials in accordance with Section 42b of the Medicines Act (AMG)

Designing publicly funded healthcare markets Note by the Russian Federation

MYCAMINE National Drug Code Directory

The Global Economic Crisis and HIV Prevention and Treatment Programmes: Vulnerabilities and Impact. Executive Summary TRINIDAD AND TOBAGO

PHENYTOIN SODIUM National Drug Code Directory

MEDICINAL PRODUCTS IN HUMAN MEDICINE ACT

DIVALPROEX SODIUM National Drug Code Directory

IPEC Japan Update. Keiji Kijima Ph.D. Feb. 6 th, 2015 Hotel Negresco Nice (France)

::Contents:: IPEC Japan Update. 1. Self-imposed Standards of Excipient GMP Self-imposed Standards of Excipient GMP 2014

Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law

ANNEX III ASEAN GUIDELINES ON LIMITS OF CONTAMINANTS FOR TRADITIONAL MEDICINES

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) FINAL

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

For personal use only

Work plan for the joint CHMP/ CVMP Quality Working Party (QWP) for 2018

Big Data & Predictive Analytics Case Studies: Applying data science to human data Big-Data.AI Summit

Some good practices in an interagency approach to the prevention of NCDs in Russia

VOCATIONAL EDUCATION AND TRAINING STANDARD FOR A PHARMACIST S ASSISTANT

Worldwide Regulatory Perspective on Herbal Drugs & Herbal formulations

REGULATORY CHALLENGES IN SOUTH AFRICA

Prospects for Malaysian Palm Oil in the CIS Region FOCUS ON THE FOOD SECTOR IN RUSSIA AND UKRAINE

Draft Guidance for Pharmacists on Extemporaneous Dispensing. Version 1

A Pragmatic Approach Towards The Regulation of Botanical Food Supplements

COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) DRAFT COMMUNITY HERBAL MONOGRAPH ON BETULA PENDULA ROTH; BETULA PUBESCENS EHRH.

Formation of Engineers' Professional Orientation at Technical Higher Educational Institutions

Background COUNTERFEITING DRUGS IS MURDER CURRENT NATIONAL LEGISLATIVE RESPONSES. 8-15% of global pharmaceutical sales is counterfeit

FOOD AND DRUGS AUTHORITY (FDA) GHANA

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

MINISTRY OF INDUSTRY AND TRADE OF THE RUSSIAN FEDERATION No. GMP-00903/18/TR STATEMENT of compliance of manufacturer (foreign manufacturer) of medicin

Transcription:

The State Pharmacopoeia of the Russian Federation XII Edition Part 1 Current state and strategy for the future

Before 12 th edition of the State Pharmacopoeia of the Russian Federation there were following editions: 1 st 1866 year 2 nd 1871 year 3 rd -1880 year 4 th 1891 year 5 th 1902 year 6 th 1910 year 7 th 1925 year 8 th -1946 year 9 th 1961 year 10 th 1968 year 11 th 1987 year (1 st part), 1990 year (2 nd part) After publication of 11 th edition of the State Pharmacopoeia General monographs, Monographs and amendments were enacted. They had the same official status as the State Pharmacopoeia. In 2007 1 st part of 12 th edition of the State Pharmacopoeia was developed by the Institute of standardization and quality control of medicinal products Federal State Budgetary Institution Scientific centre for expert evaluation of medical products, with collaboration of Scientific Research Institute of Pharmacy Moscow Medical Academy named after I.M. Sechenov (now I. M. Sechenov First Moscow State Medical University) and specialists of leading scientific centers and manufacturing enterprises. 1 st part of 12 th edition of the State Pharmacopoeia includes monographs of methods of analysis (physical and physicochemical methods), biological tests, reagents, general monographs and monographs for APIs. Rules of elaborating general monographs and monographs and including them in the State Pharmacopoeia are enacted by Federal Law No. 61-FZ of August 26, 2010.

In accordance with the Federal program Pharma-2020 strategic aim of Russian pharmaceutical industry is to bring domestic medicinal products to the international pharmaceutical market. For realization this aim it is necessary to harmonize domestic drug quality standards with requirements of leading world pharmacopoeias. The Centre of Pharmacopoeia and International collaboration is the department of the Federal State Budgetary Institution «Scientific centre for expert evaluation of medical products» Ministry of Health and Social Development of the Russian Federation. Main areas of activity of the Centre of the Pharmacopoeia and International collaboration: - Elaborating the State Pharmacopoeia, organizing appropriate studies and elaborating general monographs, monographs and other materials for further including them in the State Pharmacopoeia; - Collaboration with leading world pharmacopoeias in order to harmonize requirements to quality standards of medicinal products; - Developing and publishing guidelines in the field of standardization and quality control of medicinal products; - Establishing domestic bank of reference standards of APIs and impurities and providing them with appropriate documentation; - Participating in training specialists in the field of standardization and quality control of medicinal products; - Organizing, holding, participating in conferences, meetings and other events on domestic and international levels. In 2006 the Russian Federation got status of the observer in the European Pharmacopoeia. Plan of elaborating new parts of 12 th edition of the State Pharmacopoeia is prepared by the Centre of Pharmacopoeia and International collaboration: - 2011 year 2 nd part, including monographs for finished dosage forms, monographs for APIs, methods of analysis (physical, physicochemical and chemicals methods). - 2012 year 3 rd part, including general monographs for biologicals and their methods of analysis. - 2013 year 4 th part, including monographs for herbal products and their methods of analysis. - 2014 year 5 th part, including monographs for homeopathic products and their methods of analysis. Elaborating 12 th edition of the State Pharmacopoeia is important step in achieving the high quality of domestic medicinal products and key condition for bringing them to the international pharmaceutical market and increasing their competitiveness.

Establishing domestic bank of pharmacopoeial reference standards is another important aim for the national system of standardization and quality control of medicinal products. Ministry of Health and Social Development of the Russian Federation Department of national regulation of medicines of circulation Council of the State Pharmacopoeia Federal State Budgetary Institution «Scientific centre for expert evaluation of medical products» Centre of Pharmacopoeia and International collaboration Picture 1. Structure of departments of Ministry of Health and Social Development of the Russian Federation, engaging in developing the State Pharmacopoeia

Centre of the Pharmacopoeia and International collaboration Department of International collaboration Department of reference standards Department of Pharmacopoeia Picture 2. Structure of the Centre of Pharmacopoeia and International collaboration